
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18338231
[patent_doc_number] => 20230130180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => TREATMENT OF PAIN BY ADMINISTRATION OF SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/790429
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790429
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790429 | TREATMENT OF PAIN BY ADMINISTRATION OF SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS | Jan 5, 2021 | Abandoned |
Array
(
[id] => 16776623
[patent_doc_number] => 20210113700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => PHARMACEUTICAL COMPOSITION IN SOLID EXTRUDED FORM
[patent_app_type] => utility
[patent_app_number] => 17/134668
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17134668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/134668 | Pharmaceutical composition in solid extruded form | Dec 27, 2020 | Issued |
Array
(
[id] => 18196398
[patent_doc_number] => 20230049917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => Pharmaceutical Composition of CASR Modulators and Methods and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/789343
[patent_app_country] => US
[patent_app_date] => 2020-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789343 | Pharmaceutical Composition of CASR Modulators and Methods and Uses Thereof | Dec 25, 2020 | Pending |
Array
(
[id] => 17532454
[patent_doc_number] => 20220111063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ANTIBODY-DRUG CONJUGATES AND USE OF ANTIBODIES FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/298624
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298624
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/298624 | ANTIBODY-DRUG CONJUGATES AND USE OF ANTIBODIES FOR DRUG DELIVERY | Dec 16, 2020 | Abandoned |
Array
(
[id] => 16776409
[patent_doc_number] => 20210113486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => MULTI-SEGMENTED TRANSDERMAL DOSING UNIT AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/123848
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123848
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/123848 | MULTI-SEGMENTED TRANSDERMAL DOSING UNIT AND METHODS OF USE | Dec 15, 2020 | Abandoned |
Array
(
[id] => 18801344
[patent_doc_number] => 11834496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Composition of a drug carrier, pharmaceutical composition thereof, preparation method and use method thereof
[patent_app_type] => utility
[patent_app_number] => 17/121794
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 4321
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17121794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/121794 | Composition of a drug carrier, pharmaceutical composition thereof, preparation method and use method thereof | Dec 14, 2020 | Issued |
Array
(
[id] => 16945876
[patent_doc_number] => 20210204567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => PET-MEDICINE-CAPSULE WRAPPER APPARATUS AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/118292
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118292
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118292 | PET-MEDICINE-CAPSULE WRAPPER APPARATUS AND METHOD | Dec 9, 2020 | Abandoned |
Array
(
[id] => 16726476
[patent_doc_number] => 20210093623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Methylphenidate Extended Release Chewable Tablet
[patent_app_type] => utility
[patent_app_number] => 17/113856
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17113856
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/113856 | Methylphenidate extended release chewable tablet | Dec 6, 2020 | Issued |
Array
(
[id] => 17020961
[patent_doc_number] => 20210244832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => BIO-IMAGING PROBES AND METHODS FOR NON-INVASIVE DETECTION OF HUMAN UTERINE SARCOMAS
[patent_app_type] => utility
[patent_app_number] => 17/111485
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/111485 | BIO-IMAGING PROBES AND METHODS FOR NON-INVASIVE DETECTION OF HUMAN UTERINE SARCOMAS | Dec 2, 2020 | Abandoned |
Array
(
[id] => 18171805
[patent_doc_number] => 11571498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Drug eluting medical device
[patent_app_type] => utility
[patent_app_number] => 17/106276
[patent_app_country] => US
[patent_app_date] => 2020-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 9724
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17106276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/106276 | Drug eluting medical device | Nov 29, 2020 | Issued |
Array
(
[id] => 18091409
[patent_doc_number] => 20220409750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => NANODROPLET WITH LAYER-BY-LAYER ASSEMBLY
[patent_app_type] => utility
[patent_app_number] => 17/778733
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778733 | NANODROPLET WITH LAYER-BY-LAYER ASSEMBLY | Nov 19, 2020 | Pending |
Array
(
[id] => 18901454
[patent_doc_number] => 20240016939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => Liquid Composition Comprising Cereal Beta-Glucan or a Cereal Extract Comprising Beta-Glucan
[patent_app_type] => utility
[patent_app_number] => 18/252969
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252969
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252969 | Liquid Composition Comprising Cereal Beta-Glucan or a Cereal Extract Comprising Beta-Glucan | Nov 16, 2020 | Pending |
Array
(
[id] => 18064500
[patent_doc_number] => 20220395587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => CELLULAR MOLECULAR THERANOSTICS NANOPROBE SYSTEMS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/776663
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776663
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776663 | CELLULAR MOLECULAR THERANOSTICS NANOPROBE SYSTEMS AND METHODS | Nov 15, 2020 | Pending |
Array
(
[id] => 17936986
[patent_doc_number] => 11471418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Pharmaceutical compositions of amorphous solid dispersions and methods of preparation thereof
[patent_app_type] => utility
[patent_app_number] => 17/097789
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 50927
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17097789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/097789 | Pharmaceutical compositions of amorphous solid dispersions and methods of preparation thereof | Nov 12, 2020 | Issued |
Array
(
[id] => 18147824
[patent_doc_number] => 20230021681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => COMPOSITION AND METHOD FOR IN VIVO ASSAY OF OPIOID RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/776242
[patent_app_country] => US
[patent_app_date] => 2020-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776242 | COMPOSITION AND METHOD FOR IN VIVO ASSAY OF OPIOID RECEPTORS | Nov 10, 2020 | Pending |
Array
(
[id] => 18377246
[patent_doc_number] => 20230152333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => METHOD OF DIFFERENTIATING OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY, METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOP ATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY
[patent_app_type] => utility
[patent_app_number] => 17/906914
[patent_app_country] => US
[patent_app_date] => 2020-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906914
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906914 | METHOD OF DIFFERENTIATING OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY, METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOP ATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY | Nov 9, 2020 | Pending |
Array
(
[id] => 16627402
[patent_doc_number] => 20210046055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => Tacrolimus For Improved Treatment Of Transplant Patients
[patent_app_type] => utility
[patent_app_number] => 17/085379
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085379 | Tacrolimus for improved treatment of transplant patients | Oct 29, 2020 | Issued |
Array
(
[id] => 16619871
[patent_doc_number] => 20210038524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => EXTENDED RELEASE COMPOSITIONS COMPRISING TRIHEXYPHENIDYL
[patent_app_type] => utility
[patent_app_number] => 17/085200
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085200 | Extended release compositions comprising trihexyphenidyl | Oct 29, 2020 | Issued |
Array
(
[id] => 17073702
[patent_doc_number] => 11110081
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Tacrolimus for improved treatment of transplant patients
[patent_app_type] => utility
[patent_app_number] => 17/085291
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34924
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085291 | Tacrolimus for improved treatment of transplant patients | Oct 29, 2020 | Issued |
Array
(
[id] => 17095327
[patent_doc_number] => 20210283118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => FORMULATIONS OF PIMAVANSERIN
[patent_app_type] => utility
[patent_app_number] => 17/080731
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080731 | FORMULATIONS OF PIMAVANSERIN | Oct 25, 2020 | Abandoned |